20350
ORBO™ 49P (OVS) Supelpak™-20 specially treated Amberlite™ XAD®-2 (20/40), 270/140 mg
RC,GFF,F,F (specially cleaned) separators, O.D. × L 13-8 mm × 75 mm , OSHA Versatile Sampler (OVS) Tube, pkg of 10 ea
Synonym(s):
ORBO™ Supelpak™ 20 series Tube
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
47131900
Recommended Products
material
RC,GFF,F,F (specially cleaned) separators
Quality Level
Agency
NIOSH 5601
OSHA 62,63,67,70,74
product line
Amberlite™
ORBO™
composition
Bed A, 270 mg
Bed B, 140 mg
packaging
pkg of 10 ea
manufacturer/tradename
ORBO™ 49P
technique(s)
active air sampling: suitable
O.D. × L
13-8 mm × 75 mm , OSHA Versatile Sampler (OVS) Tube
matrix
XAD-2 (specially cleaned)
particle size
20-40 mesh
application(s)
air monitoring
environmental
industrial hygiene
Looking for similar products? Visit Product Comparison Guide
General description
The OSHA Versatile Sampler (OVS) was primarily designed for collection of Organophosphorus pesticides but is suitable for other applications. This specially constructed open glass tube is 75 mm long with a 13-mm outer diameter (O.D.) on the inlet end tapered to 8 mm (O.D.) on the outlet end. The design features a glass filter to trap the aerosols and a two-section sorbent portion to adsorb the vapors. The tube is packed with specially cleaned XAD-2 material and is QA tested to ensure low background interferences. The product is capped at the inlet and outlet to minimize environmental exposure. Meets OSHA and NIOSH method design specifications.
Legal Information
Amberlite is a trademark of DuPont de Nemours, Inc.
ORBO is a trademark of Sigma-Aldrich Co. LLC
Supelpak is a trademark of Sigma-Aldrich Co. LLC
XAD is a registered trademark of The Dow Chemical Company or an affiliated company of Dow
Storage Class Code
10 - Combustible liquids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
F J Egea González et al.
Journal of AOAC International, 80(5), 1091-1097 (1997-11-05)
A method to sample and analyze chlorothalonil and dichlofluanid in greenhouse air was evaluated. Analysis was performed by gas chromatography with electron capture detection and gas chromatography-mass spectrometry. Solid sorbents such as Chromosorb 102, Porapak R, Supelpak-2, Amberlite XAD-2, Amberlite
K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
Chromatograms
suitable for GC, application for air monitoringOur team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service